Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells
CA 2492475 A1 · Owner: Woomera Therapeutics, Inc. · Inventors: Keegan, Brendan P.; Oligino, Lyn; North, William G.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention discloses antibodies antigen binding fragments, peptides and peptidomimetics immunoreactive with provasopressin and compositions thereof, methods of phenotyping tissue samples methods of , treating cancer, and kits for phenotyping test biopsy samples and bodily fluids for breast cancer, small cell lung cancer ductal carcinoma in situ, and atypical ductal hyperplasia.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 16, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 16, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 16, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.